EQT, a private equity firm, and ATHOS, a venture capital firm, agreed to invest in SHL Medical, a provider of drug delivery solutions. Roger Samuelsson, SHL Medical founder, will remain the majority shareholder. Financial terms were not disclosed. “Above all else, SHL Medical’s success has been predicated on an unresolving commitment to improving the lives of patients. We have a great partnership with EQT and are excited to work closely with EQT Future, ATHOS and the other co-investors to accelerate our global expansion and to develop new drug delivery solution offerings. Together, we will continue to build and grow the company to provide the best possible service to our customers and for patients around the globe," Ulrich Faessler, SHL CEO.